244 related articles for article (PubMed ID: 10897434)
1. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
4. Expression of rasGTPase activating protein in basal cell carcinoma of the skin.
Barshack I; Goldberg I; Davidson B; Ravid A; Schiby G; Kopolovic J; Leviav A; Friedman E
Mod Pathol; 1998 Mar; 11(3):271-5. PubMed ID: 9521474
[TBL] [Abstract][Full Text] [Related]
5. The expression of p63 in basal cell carcinomas and association with histological differentiation.
Bircan S; Candir O; Kapucoglu N; Baspinar S
J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
[TBL] [Abstract][Full Text] [Related]
6. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin profile in basal cell carcinoma.
Alessi E; Venegoni L; Fanoni D; Berti E
Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
[TBL] [Abstract][Full Text] [Related]
9. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
10. [Depth of invasion of basaliomas].
Breuninger H; Flad P; Rassner G
Z Hautkr; 1989 Mar; 64(3):191-6. PubMed ID: 2718551
[TBL] [Abstract][Full Text] [Related]
11. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
13. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
14. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells.
Chu CY; Cha ST; Chang CC; Hsiao CH; Tan CT; Lu YC; Jee SH; Kuo ML
Oncogene; 2007 Apr; 26(17):2491-501. PubMed ID: 17099730
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
[TBL] [Abstract][Full Text] [Related]
16. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
17. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
18. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
19. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
20. Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas.
Chan MM; Tahan SR
J Cutan Pathol; 2010 Mar; 37(3):336-43. PubMed ID: 19615036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
